tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EUDA Health to Launch Helixé 2.0 Longevity Supplement with Halal Certification in January 2026

Story Highlights
  • EUDA Health will launch EUDA Helixé 2.0 in January 2026, featuring a stronger formulation, advanced delivery technology and new premium packaging to enhance potency and user experience.
  • New Zealand Halal certification for EUDA Helixé 2.0 supports EUDA Health’s planned expansion into Muslim markets across Southeast Asia, the Middle East and other global regions, reinforcing its longevity-focused growth strategy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EUDA Health to Launch Helixé 2.0 Longevity Supplement with Halal Certification in January 2026

Claim 70% Off TipRanks Premium

An announcement from EUDA Health Holdings ( (EUDA) ) is now available.

On December 29, 2025, EUDA Health Holdings announced that it will launch EUDA Helixé 2.0, the next-generation version of its premium youthful vitality and longevity supplement, in January 2026. The upgraded product features a 20% increase in New Zealand deer placenta powder, a reformulated antioxidant profile with Vitamin E to support cellular protection and skin health, and advanced delivery technologies such as freeze drying, refined oil processing, nitrogen encapsulation and nano emulsification to enhance stability, absorption and shelf life. EUDA is also rolling out a new proprietary bottle design to strengthen brand positioning and product protection, while securing New Zealand Halal certification to support expansion into Muslim markets across Southeast Asia, the Middle East and other regions. The company positions Helixé 2.0 as a core pillar of its growing health and longevity ecosystem, reinforcing its strategy to scale premium, science-based wellness offerings globally and deepen its presence in high-growth preventive healthcare and longevity markets.

The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.

More about EUDA Health Holdings

EUDA Health Holdings Limited is a Singapore-based, non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, with a strategic emphasis on preventive care and the fast-growing longevity sector. Listed on Nasdaq, the company targets the evolving needs of more than 1.8 billion people in rapidly aging regional populations by offering innovative, science-backed health and wellness solutions, and also operates a Singapore-based property management business.

Average Trading Volume: 256,056

Technical Sentiment Signal: Sell

Current Market Cap: $92.63M

See more data about EUDA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1